(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Endometriosis Pain pipeline constitutes 5+ key companies continuously working towards developing 5+ Endometriosis Pain treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
“Endometriosis Pain Pipeline Insight, 2023“ report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Endometriosis Pain Market.
The Endometriosis Pain Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.
Some of the key takeaways from the Endometriosis Pain Pipeline Report:
- Companies across the globe are diligently working toward developing novel Endometriosis Pain treatment therapies with a considerable amount of success over the years.
- Endometriosis Pain companies working in the treatment market are Organon, Ironwood Pharmaceuticals, Mitsubishi Tanabe Pharma Corporation, AbbVie/Neurocrine Biosciences, ObsEva/Kissei Pharmaceuticals, SWK/Enteris BioPharma, Bayer/Hope Medicine, Tiumbio, and others, are developing therapies for the Endometriosis Pain treatment
- Emerging Endometriosis Pain therapies in the different phases of clinical trials are- FOR 6219, IW-3300, MT-2990, ORIAHNN (elagolix/estradiol/norethindrone acetate), Linzagolix (OBE2109), OVAREST (leuprorelin oral), HMI-115, TU2670 (NCE-403), OG-6219, and others are expected to have a significant impact on the Endometriosis Pain market in the coming years.
- In April 2022, A MoH application for HMI-115 was received in the first European nation.
- In March 2020, “A Double-blind Randomised Extension Study to Assess the Long-term Efficacy and Safety of Linzagolix in Subjects With Endometriosis-Associated Pain” was the name of the experiment that Obseva started. This study is prospective, double-blind, and randomized.
- ObsEva has a partnership with Syneos for the American market’s commercialization of linzagolix, and a licencing deal with Theramex for the international markets outside of North America, Asia, and Europe.
Endometriosis Pain Overview
Endometriosis is a condition marked by the uncontrolled expansion of tissue that resembles endometrium outside the uterus. When a woman is not pregnant, endometrial tissue naturally borders the uterus and thickens and degrades as part of the monthly cycle. The abnormal growths, or lesions, typically form on or around the reproductive organs, on the bowels, or on the bladder, however they can form anywhere.
Get a Free Sample PDF Report to know more about Endometriosis Pain Pipeline Therapeutic Assessment- https://www.delveinsight.com/report-store/endometriosis-pain-pipeline-insight
Emerging Endometriosis Pain Drugs Under Different Phases of Clinical Development Include:
- FOR 6219: Organon
- IW-3300: Ironwood Pharmaceuticals
- MT-2990: Mitsubishi Tanabe Pharma Corporation
- ORIAHNN (elagolix/estradiol/norethindrone acetate): AbbVie/Neurocrine Biosciences
- Linzagolix (OBE2109): ObsEva/Kissei Pharmaceuticals
- OVAREST (leuprorelin oral): SWK/Enteris BioPharma
- HMI-115: Bayer/Hope Medicine
- TU2670 (NCE-403): Tiumbio
- OG-6219: Organon
- Quinagolide: Ferring Pharmaceuticals
- Linzagolix: ObsEva
Endometriosis Pain Route of Administration
Endometriosis Pain pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
- Intravenous/ Subcutaneous
Endometriosis Pain Molecule Type
Endometriosis Pain Products have been categorized under various Molecule types, such as
- Antisense oligonucleotides
- Monoclonal antibody
- Recombinant protein
- Small molecule
- Stem Cell
Endometriosis Pain Pipeline Therapeutics Assessment
- Endometriosis Pain Assessment by Product Type
- Endometriosis Pain By Stage and Product Type
- Endometriosis Pain Assessment by Route of Administration
- Endometriosis Pain By Stage and Route of Administration
- Endometriosis Pain Assessment by Molecule Type
- Endometriosis Pain by Stage and Molecule Type
DelveInsight’s Endometriosis Pain Report covers around 5+ products under different phases of clinical development like
- Late-stage products (Phase III)
- Mid-stage products (Phase II)
- Early-stage product (Phase I)
- Pre-clinical and Discovery stage candidates
- Discontinued & Inactive candidates
- Route of Administration
Further Endometriosis Pain product details are provided in the report. Download the Endometriosis Pain pipeline report to learn more about the emerging Endometriosis Pain therapies
Some of the key companies in the Endometriosis Pain Therapeutics Market include:
Key companies developing therapies for Endometriosis Pain are – AbbVie, Neurocrine Biosciences, Kissei Pharmaceuticals, SWK, Enteris BioPharma, Bayer, Hope Medicine, Tiumbio, Organon, Ferring Pharmaceuticals, ObsEva SA, Myovant Sciences, Hope Medicine (Nanjing) Co., Ltd, TiumBio Co., Ltd., Mitsubishi Tanabe Pharma, and others.
Endometriosis Pain Pipeline Analysis:
The Endometriosis Pain pipeline report provides insights into
- The report provides detailed insights about companies that are developing therapies for the treatment of Endometriosis Pain with aggregate therapies developed by each company for the same.
- It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Endometriosis Pain Treatment.
- Endometriosis Pain key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
- Endometriosis Pain Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
- Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Endometriosis Pain market.
The report is built using data and information traced from the researcher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Download Sample PDF Report to know more about Endometriosis Pain drugs and therapies
Endometriosis Pain Pipeline Market Drivers
- The development of drug delivery systems represents a new approach in pain treatment among endometriosis patients, extensive research on Non-steroidal anti-inflammatory drugs are some of the important factors that are fueling the Endometriosis Pain Market.
Endometriosis Pain Pipeline Market Barriers
- However, less robust pipeline, high cost of treatment procedures and other factors are creating obstacles in the Endometriosis Pain Market growth.
Scope of Endometriosis Pain Pipeline Drug Insight
- Coverage: Global
- Key Endometriosis Pain Companies: , and others
- Key Endometriosis Pain Therapies: FOR 6219, IW-3300, MT-2990, ORIAHNN (elagolix/estradiol/norethindrone acetate), Linzagolix (OBE2109), OVAREST (leuprorelin oral), HMI-115, TU2670 (NCE-403), OG-6219, and others
- Endometriosis Pain Therapeutic Assessment: Endometriosis Pain current marketed and Endometriosis Pain emerging therapies
- Endometriosis Pain Market Dynamics: Endometriosis Pain market drivers and Endometriosis Pain market barriers
Request for Sample PDF Report for Endometriosis Pain Pipeline Assessment and clinical trials
Table of Contents
- Endometriosis Pain Report Introduction
- Endometriosis Pain Executive Summary
- Endometriosis Pain Overview
- Endometriosis Pain- Analytical Perspective In-depth Commercial Assessment
- Endometriosis Pain Pipeline Therapeutics
- Endometriosis Pain Late Stage Products (Phase II/III)
- Endometriosis Pain Mid Stage Products (Phase II)
- Endometriosis Pain Early Stage Products (Phase I)
- Endometriosis Pain Preclinical Stage Products
- Endometriosis Pain Therapeutics Assessment
- Endometriosis Pain Inactive Products
- Company-University Collaborations (Licensing/Partnering) Analysis
- Endometriosis Pain Key Companies
- Endometriosis Pain Key Products
- Endometriosis Pain Unmet Needs
- 16 . Endometriosis Pain Market Drivers and Barriers
- Endometriosis Pain Future Perspectives and Conclusion
- Endometriosis Pain Analyst Views
- About DelveInsight
Endometriosis Pain Market
DelveInsight’s ‘Endometriosis Pain Market Insights, Epidemiology, and Market Forecast—2032’ report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom),
Protein Supplements Market By Source (Animal-Based [Whey, Casein, Fish, Eggs, Others], Plant-Based [Soy, Rice, Pea, Spirulina, Others]), By Product Type (Protein Powders, Protein Bars, Ready-To-Drink, And Others), By Application (Sports Nutrition And Functional Foods), By Distribution Channel (Supermarkets And Hypermarkets, E-Commerce, Direct-To-Consumer, Others), by geography is estimated to register growth at a remarkable CAGR forecast during 2022-2027 owing to the growing consumer awareness of having a protein rich diet,
Proteomics Market By Product & Services (Instrumentation Technology [Spectroscopy, Chromatography, Electrophoresis, Protein Microarrays, X-Ray Crystallography, And Other], Reagents & Consumables, And Software & Services), By Application (Clinical Diagnostics, Drug Discovery, And Others), By End-User (Hospitals, Clinical Laboratories, Pharmaceutical Companies, And Others), and by geography is expected to advance at a respectable CAGR forecast till 2028.
Infrared Thermometer Market By Product Type (Contact Thermometers And Non-Contact Thermometers), By End-User (Food And Beverage Industry, Electronic Industry, Healthcare Industry, And Others), and by geography is expected to advance at a respectable CAGR forecast till 2028 owing to the growing need for robust temperature measuring devices in critical industries and rise in the number of infectious diseases across the globe.
Hemoglobinopathies Market By Indication (Thalassemia, Sickle Cell Anaemia, And Others), By Treatment (Stem Cell Therapy, Blood Transfusion, Iron Chelation Therapy, And Others), and by geography is expected to advance at a respectable CAGR forecast till 2027 owing to the increasing prevalence of various hemoglobin disorders and the increasing research & developmental activities concerning to the hemoglobinopathies across the globe
The Sports Nutrition Market By Product Type (Sports Drinks And Sports Supplements), By Distribution Channels (Hypermarkets & Supermarkets, E-Commerce, And Others), and by geography is expected to grow at a steady CAGR forecast till 2028 owing to the increasing inclination toward following healthy and active lifestyle and growing importance of sports nutrition among athletes and sportspersons.
Endodontic Devices Market By Product Type (Instruments [Apex Locators, Endodontic Motors, Endodontic Scalers, Endodontic Lasers, Handpieces, Machine-Assisted Obturation Systems, And Others], Consumables [Obturation, Access Cavity Preparation, Shaping And Cleaning]), By End-User (Dental Hospitals, Dental Clinics, And Others), and by geography is estimated to register growth at a remarkable CAGR during the forecast period from 2023-2028 owing to the rising patient pool associated with dental disorders, poor oral health, leading to increased number of root canal treatments, the increasing population opting for dental aesthetics, among others across the globe.
mRNA Vaccines And Therapeutics Market By Vaccine Type (Self-Amplifying Mrna Based Vaccines And Conventional Non-Amplifying mRNA Based Vaccines), By End-User (Hospitals And Clinics, Research And Development Organizations, And Others), and by geography is expected to grow at a steady CAGR forecast till 2028 owing to the rising demand for protection against sudden pandemic outbreaks and the increasing patient pool associated with infectious diseases across the globe, among others.
Hydrocephalus Shunts Market By Product (Hydrocephalus Valves [Adjustable Pressure Valves And Fix Pressure Valves], Hydrocephalus Catheters, And Others), By Age Group (Paediatric And Adults), By End-User (Hospitals, Ambulatory Surgical Centers, And Others), and by geography is expected to advance at a respectable CAGR forecast till 2028 owing to the rising prevalence of brain and neurological disorders and growing use of sophisticated programmable valves across the globe.
Contrast Media Injectors Market By Product (Injector Systems [Ct Injector Systems, Mri Injector Systems, And Cardiovascular/Angiography Injector Systems] And Consumables [Tubing, Syringe, And Other]), By Type Of Injectors (Single-Head Injectors, Dual-Head Injectors, And Syringeless Injectors), By Application (Radiology, Interventional Cardiology, And Others), and by geography is expected to advance at a respectable CAGR forecast till 2028 owing to the rising prevalence of chronic diseases across the globe and surging demand of minimally invasive surgeries.
Body Temperature Monitoring Market By Product Type (Contact [Digital Thermometers, Disposable Thermometers, Infrared Ear Thermometers, Mercury Thermometers, Temporal Artery Thermometers, And Others} And Non-Contact), By Application (Oral Cavity, Rectum, Ear, And Others), By End-User (Homecare Settings, Hospitals And Clinics, And Others), by geography is estimated to register growth at a remarkable CAGR forecast during 2023-2028 owing to rising prevalence of chronic and infectious diseases and increasing technological advancements.
Medical Device Cleaning Market By Detergent Type (Enzymatic And Non-Enzymatic), By Process (Cleaning [Pre-Cleaning, Manual Cleaning, And Automatic Cleaning] And Disinfection [High-Level Disinfection, Intermediate-Level Disinfection, And Low-Level Disinfection), By Application (Endoscope, Surgical Instruments, And Others), by geography, is estimated to register growth at a remarkable CAGR forecast during 2023-2028 owing to rising prevalence of healthcare-associated infections and increasing number of surgical procedures.
Chemotherapy Drugs Market By Drug Class (Alkylating Agents, Mitotic Inhibitors, Antimetabolites, Topoisomerase Inhibitors, And Others), By Indication (Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, And Others), By Route Of Administration (Oral And Parenteral), by geography is estimated to register growth at a remarkable CAGR forecast during 2023-2028 owing to increasing prevalence of different cancer types and increasing pharmaceutical trials for chemotherapy drugs.
Related Reports By DelveInsight
Calciphylaxis Market | Anorexia Nervosa Market | Cervical Cancer Market | Drug Resistant Epilepsy Market | Abetalipoproteinemia Market | Polycythemia Market | Ambulatory Arrhythmia Monitoring Devices Market | Choroidal Neovascularization Market | Pruritus Market | Cardiopulmonary Bypass Equipment Market | Chemotherapy Induced Anemia Market | Chronic Bronchitis Market | Clbp Market | Hearing Implants Market | Neurovascular Devices Market | Pemphigus Vulgaris Market | Polycythemia Vera Market | Advanced Renal Cell Carcinoma Market | Airway Stent Market Market | Allergic Conjunctivitis Market | Alopecia Areata Market | Alport Syndrome Market | Angioedema Market | Bladder Pain Syndrome Market | Bone Densitometers Market | Brain Aneurysm Stents Market | Calciphylaxis Market | Chronic Inflammatory Demyelinating Polyneuropathy Market | Chronic Inflammtory Demyelinating Polyneuropathy Market | Chronic Myelogenous Leukemia Market | Cutaneous T-cell Lymphoma Market | Defibrillators Market | Dermal Erythema Market | Eczema Market | Body Temperature Monitoring Market | Medical Device Cleaning Market | Chemotherapy Drugs Market | Connected Drug Delivery Devices Market | Gynecological Devices Market | Baby Wipes Market | Probiotics Market | Artificial Tears Market | Non-invasive Prenatal Testing Market | Orthopedic Implants Market | Analgesics Market | Animal Nutrition Market | Point of Care Diagnostics Market | Hyaluronic Acid Viscosupplementation Market | Frozen Food Market | Intrauterine Pressure Catheters Market | PET-MRI Systems Market | Transcatheter Heart Valve Replacement Devices Market | Vaginal Slings Market | Prostate Cancer Market | Gene Therapy Market
Recent Blog’s By DelveInsight:
- Emerging Market for Organ on a Chip
- Evaluating the Upcoming Drugs in Pipeline for Major Autoimmune Diseases
- Key Pharma Companies Expanding their Arm in the Skin Cancer Segment
- Vagus Nerve Stimulators Market Outlook
- Roche’s HER2-Positive Breast Cancer Treatment Franchise
- Robotic Surgery: Navigating the Growing Demand, Ongoing Trends & Developments in the Global Market
- Graft-Versus-Host Disease (GvHD) Treatment Market: A Moving Target For Therapies
- Healthcare Delivery System: What lies in the future?
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.